Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check36 days agoNo Change Detected
- Check50 days agoChange DetectedThe website has been updated to version 2.10.0, which includes the addition of 2 more interventions/treatments, replacing the previous version 2.9.7.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check70 days agoChange DetectedThe change in the web page value represents an update to the DOI (Digital Object Identifier) for the Erratum in the Lancet publication related to the study on Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis.SummaryDifference0.0%
- Check71 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.SummaryDifference0.0%
Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.